|
1）Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011; 364: 2305-15
|
|
|
|
2）Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 27: 949-54
|
|
|
|
|
|
3）Arcaini L, Zibellini S, Boveri E, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012; 119: 188-91
|
|
|
|
|
|
4）Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2012; 119: 192-5
|
|
|
|
|
|
5）Xi L, Arons E, Navarro W, et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012; 119: 3330-2
|
|
|
|
|
|
6）Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011; 364: 2507-16
|
|
|
|
|
|
7）Dietrich S, Glimm H, Andrulis M, et al. BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med. 2012; 366: 2038-40
|
|
|
|
|
|
8）Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446: 153-8
|
|
|
|
|
|
9）Flaherty KT, Robert C, Hersey P, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012; 367: 107-14
|
|
|
|
|
|
10）Halilovic E, Solit DB. Therapeutic strategies for inhibiting oncogenic BRAF signaling. Curr Opin Pharmacol. 2008; 8: 419-26
|
|
|
|
|
|
11）Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008; 456: 66-72
|
|
|
|
|
|
12）Keshet Y, Seger R. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol. 2010; 661: 3-38
|
|
|
|
|
|
13）Kamiguti AS, Harris RJ, Slupsky JR, et al. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene. 2003; 22: 2272-84
|
|
|
|
|
|
14）Takahashi Y, Mori J. BRAF mutations in hairy-cell keukemia. N Engl J Med. 2011; 365: 960-1
|
|
|
|
|
|
15）Tiacci E, Rabadan R, Falini B. BRAF mutations in hairy-cell keukemia. N Engl J Med. 2011; 365: 961-2
|
|
|
|
|
|
16）Slupsky JR, Kamiguti AS, Harris RJ, et al. Central role of protein kinase C? in constitutive activation of ERK 1/2 and Rac1 in the malignant cells of hairy cell leukemia. Am J Pathol. 2007; 170: 745-54
|
|
|
|
|
|
17）Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011; 471: 467-72
|
|
|
|
|